Matrine Sodium Chloride Injection

This product can inhibit the occurrence of cachexia in tumor-bearing mice, inhibit the growth of cancer cells, and prolong the survival time of tumor-bearing mice by more than double. This product can inhibit the production of cachectin in tumor cells, and also inhibit the effect of cachectin on normal cells, thereby preventing cachexia in tumor patients.

Oxymatrine

This product is a colorless or almost colorless clear liquid.

Mainly used for the treatment of chronic hepatitis B

Intravenous drip. Once a day, 0.4-0.6g each time. 2 months as a course of treatment, or as directed by the doctor.

Patients have good tolerance to this product, and the incidence of adverse reactions is low. The main adverse reactions are dizziness, vomiting, bitter taste in the mouth, diarrhea, upper abdominal discomfort or pain, and occasionally rash, chest tightness, and fever. Symptoms generally resolve on their own. Some viruses may cause redness at the injection site.

1. Patients who are allergic to this product are prohibited from using it. 2. Patients with severe blood, heart, liver, kidney and endocrine diseases are prohibited from using it.

It has a synergistic effect with central nervous system depressants such as chloral hydrate, an antagonistic effect on central nervous system stimulants such as amphetamine, and can facilitate the convulsive effect of strychnine.

Store in a cool, dry place.

100ml: 0.6g matrine (as oxymatrine), 0.9g sodium chloride

Jiangxi Gannan Haixin Pharmaceutical Co., Ltd.

• Founded in:

  2001-12-31

• Address:

  No. 209, Lakeside Avenue, Ganzhou Economic and Technological Development Zone, Ganzhou City, Jiangxi Province

• Tax NO.:

  91360700733914344A

• Registered Funds:

  100 million yuan

• Website:

  Log in to view

• Email:

  Log in to view